• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

RBC downgrades Applied Therapeutics as FDA rejects Govorestat, hacks price target

by November 29, 2024
written by November 29, 2024

Investing.com — RBC Capital Markets downgraded Applied Therapeutics Inc (NASDAQ:APLT) stock to “sector perform” from “outperform” citing increased risks after the U.S. Food and Drug Administration (FDA) rejected the company’s application for its experimental drug govorestat to treat galactosemia.

Shares of Applied Therapeutics plunged 75% to $2 in premarket trading on Friday.

RBC analyst Brian Abrahams in a note said the FDA’s issuance of a Complete Response Letter (CRL) for govorestat creates “significant uncertainties” about the drug’s future in the rare metabolic disorder, where no approved treatments exist.

Abrahams said the FDA may require an additional clinical trial with more definitive outcomes, even though the company had already expressed openness to a narrower label or accelerated approval based on existing data.

The analyst highlighted potential value in Applied Therapeutics’ SORD deficiency program, which targets a larger patient population.

Tough doubts remain over whether the company can present a “convincing enough data package” to regulators, with a new drug application (NDA) submission expected only in the first quarter of 2025.

“There remain uncertainties as to whether APLT can assemble a convincing enough data package, and this will take time to play out,” Abrahams said, as he hacked price target for Applied Therapeutics to $4 from $12.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Aegon gets “buy” rating from BofA, shares up
next post
China’s Kaisa Group to issue US dollar-denominated mandatory convertible bonds, senior notes

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks

      June 26, 2025
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

      June 26, 2025
    • Bumble shares jump 26% as dating company plans to axe 30% of workforce

      June 26, 2025
    • Small-business AI use is lagging, but one firm is channeling Sherlock Holmes and knocking out ‘grunt work’

      June 25, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (534)
    • Stock (6,426)

    Latest News

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

    Popular News

    • Exclusive-Trump transition recommends scrapping car-crash reporting requirement opposed by Tesla
    • Citi cuts Sony TP on iPhone 16 disappointment, limited PS5 Pro impact

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy